HONG KONG – A University of Hong Kong (HKU) study has shown that a new small-molecule non-antibiotic compound has potent efficacy against methicillin-resistant Staphylococcus aureus (MRSA), making it a promising lead compound for developing anti-virulence drugs against S. aureus.